CB2 receptor agonist

This page covers all CB2 receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CB2.

Targets

CB2

Phase 2 pipeline (2)

• APD356 · Eisai Inc. · Neurology
  APD356 is a selective agonist of the cannabinoid receptor type 2 (CB2).
• CT327 ointment · Creabilis SA · Pain management
  CT327 ointment is a topical treatment that targets the cannabinoid receptor type 2 (CB2) to reduce inflammation and pain.